Where do new medicines start? They start in the lab, where scientists study the biological mechanisms that contribute to good health or, when they go awry, cause disease. Beaker highlights interesting science, Sanford-Burnham Medical Research Institute and our supporters.
Beaker's Latest Posts
Researchers have found a novel avenue for therapeutic intervention of pancreatic cancer - the "silent cancer."
Sanford-Burnham researchers recently discovered a key role of a protein called SOX2 in neuronal development. SOX2 promotes the activation of genes involved in differentiation, enabling neural progenitor cells to turn into mature neurons in the brains of adult mice.
The AACR Annual Meeting is a must-attend event for cancer investigators in every area of cancer. The meeting connects people and ideas that will lead to better prevention, diagnosis, and treatment of cancer.
Cancer metabolism is a relatively new and exciting field of biology that holds promise for new drugs that target the chemical processess that keep tumors alive.
George Kyriazis, Ph.D., joined the Institute's Orlando campus as a faculty member a few weeks ago. We sat down with George last week to discuss his background, research interest, and life outside of work.
Log in to leave a comment